HomeKURN • SWX
add
Kuros Biosciences AG
Previous close
CHFÂ 15.08
Day range
CHFÂ 15.04 - CHFÂ 15.58
Year range
CHFÂ 1.76 - CHFÂ 16.60
Market cap
568.00M CHF
Avg Volume
269.20K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 15.92M | 147.51% |
Operating expense | 14.46M | 89.64% |
Net income | -105.50K | 95.82% |
Net profit margin | -0.66 | 98.32% |
Earnings per share | — | — |
EBITDA | 197.50K | 112.68% |
Effective tax rate | 119.25% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.28M | -15.33% |
Total assets | 77.30M | -1.22% |
Total liabilities | 17.13M | 19.81% |
Total equity | 60.18M | — |
Shares outstanding | 21.10M | — |
Price to book | 5.29 | — |
Return on assets | -0.90% | — |
Return on capital | -1.12% | — |
Cash Flow
Net change in cash
| (CHF) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -105.50K | 95.82% |
Cash from operations | -158.00K | 95.32% |
Cash from investing | -307.00K | -567.39% |
Cash from financing | 264.00K | 270.87% |
Net change in cash | 34.50K | 100.96% |
Free cash flow | 1.62M | 333.01% |
About
Founded
2016
Website
Employees
106
